Search filters

List of works by Andrea Rubbert-Roth

A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis

scientific article published on 17 February 2017

A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumato

scientific article published on 31 July 2013

Assessing the safety of biologic agents in patients with rheumatoid arthritis ⬇️

scientific article published on July 1, 2012

Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

scientific article published on 13 May 2020

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

scientific article published on 21 November 2012

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

scientific article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

scientific article published on 6 March 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

scientific article published on 22 January 2020

Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials

scientific article

Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases ⬇️

scientific article (publication date: 13 December 2010)

Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).

scientific article published on 15 September 2012

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)

scientific article published on 8 June 2015

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

scientific article

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs

scientific article published on 14 August 2013

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

scientific article published on 22 September 2020

Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics

scientific article published on 13 February 2015

Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure ⬇️

scientific article published on March 1, 2013

MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

scientific article published on 17 February 2014

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab

scientific article published on 10 May 2016

Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis

scientific article published on 21 August 2016

Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs

scientific article published on July 2012

Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative

scientific article published on 16 March 2016

Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis ⬇️

scientific article published on September 16, 2011

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients

scientific article

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

scientific article published on 13 May 2011

Spectrum of Uveitis in A German Tertiary Center: Review of 474 Consecutive Patients

scientific article

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE ⬇️

scientific article published on October 19, 2011

TRU-015, a fusion protein derived from an anti-CD20 antibody, for the treatment of rheumatoid arthritis

scientific article

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

scientific article

To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50.

scientific article published on 22 October 2011

Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial

scientific article published on 7 April 2017

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

scientific article published on 28 October 2015

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

scientific article published on 06 April 2009

Paulina is supported by:

About Paulina

Help